NFKB1 and Hyperglycemia: Additionally, miR-7-5p upregulation was found to be cardio-adverse as it was predicted to activate inflammatory response, atherosclerosis, hyperglycemia, cardiovascular disease as well as inhibit angiogenesis and STAT3 and NF-KB pathway.